Utah-based health system Intermountain Healthcare will be offering Grail’s Galleri multicancer early detection blood test as a complement to existing single-cancer screenings.
Grail's test will be available beginning this month to Intermountain health system patients who are at elevated risk for cancer, such as adults ages 50 and older or those with additional risk factors, according to Grail. Furthermore, eligible employees and their families who are enrolled in a company-sponsored health plan will also be able to receive a test from Intermountain.
